NGT Healthcare II invests in early-stage Israeli life sciences and medical device startups, leveraging non-dilutive government funding (IIA) to reduce risk. The fund partners with leading Israeli universities, hospitals, and multinational corporations to create value for portfolio companies while aligning with UN Sustainable Development Goals (SDGs) and fostering social impact.
Preferred startup development maturity for initial funding deployment.
Early-stage medical device and life sciences technologies with non-dilutive leverage via Israel’s Innovation Authority (IIA)
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...